Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02733692 · ClinicalTrials.gov registry record · NA
Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation
A NA study, sponsored by City University of New York, School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02733692 is a NA study that has completed, run by City University of New York, School of Public Health. The registered enrollment target is 110 participants.
The verdict
NCT02733692, a NA study, has completed, sponsored by City University of New York, School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Smartphone applications and mobile technologies offer users the potential to access critical information (e.g., proper condom use, directions to testing sites, and other sexual and reproductive health services) when it is needed most. Relevant findings will identify areas where existing interventions may be leveraged and adapted to work among young women of color in an urban setting and their networks. As SRH smartphone apps continue to proliferate, this study will expand researchers', developers', and health educators' limited knowledge about the feasibility, acceptability and preliminary efficacy of a sexual health educational app tailored with and for young Black and Latino women, aged 18-25 in NYC, including whether this app acts as a gateway to sexual health educators, clinical and other service providers. If proven effective, findings from this study will identify areas where existing interventions may be leveraged and adapted to work among a YBLW and their networks, and potentially adapted for other high needs communities.
Interventions
- BEHAVIORAL Understanding Reproductive Health for Ladeez (GURHL) Code
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02733692
The ClinicalTrials.gov registry entry for NCT02733692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City University of New York, School of Public Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Understanding Reproductive Health for Ladeez (GURHL) Code is the first listed.
NCT02733692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02733692 about?
NCT02733692 is a clinical study titled "Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation". Smartphone applications and mobile technologies offer users the potential to access critical information (e.g., proper condom use, directions to testing sites, and other sexual and reproductive health services) when it is needed most. Relevant findings will identify areas where existing intervention...
What is the current status of trial NCT02733692?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02733692?
The interventions under investigation include: Understanding Reproductive Health for Ladeez (GURHL) Code (BEHAVIORAL).
Who is sponsoring clinical trial NCT02733692?
This trial is sponsored by City University of New York, School of Public Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.